Tse, G. ., Emmanuel, B. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., … Price, D. . (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565–2580. http://doi.org/10.2147/copd.s433326
V. Carter
First name
V.
Last name
Carter
Chen, S. ., Miravitlles, M. ., Rhee, C. K., Pavord, I. D., Jones, R. ., Carter, V. ., … Price, D. B. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187–2200. http://doi.org/10.2147/copd.s378649
Heatley, H. ., Tran, T. N., Bourdin, A. ., Menzies-Gow, A. ., Jackson, D. J., Maslova, E. ., … Price, D. B. (2022). Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax. http://doi.org/10.1136/thorax-2022-219642
Tran, T. N., Kerkhof, M. ., Carter, V. ., & Price, D. B. (2021). Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study. J Asthma Allergy, 14, 727–742. http://doi.org/10.2147/jaa.s306416
Voorham, J. ., Roche, N. ., Benhaddi, H. ., van der Tol, M. ., Carter, V. ., van Boven, J. F. M., … Price, D. B. (2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051
Price, D. B., Carter, V. ., Martin, J. ., Gardener, E. A., Skinner, D. ., Yang, S. ., … Cooper, A. J. (2019). Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care. Drugs. http://doi.org/10.1007/s40265-019-01224-8
Kerkhof, M. ., Voorham, J. ., Dorinsky, P. ., Cabrera, C. ., Darken, P. ., Kocks, J. W., … Price, D. B. (2020). Association between COPD exacerbations and lung function decline during maintenance therapy. Thorax. http://doi.org/10.1136/thoraxjnl-2019-214457